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CHAPTER I 
INTRODUCTION 
There is abundant evidence implicating microorganisms as the primary 
1,2,3,4,5 
cause of the periodontal diseases. Loe and coworkers demon-
strated that withdrawal of all measures of oral hygiene in healthy sub-
jects resulted in marginal gingivitis. Moreover, upon reinstitution of 
rigorous oral hygiene the bacterial plaque was reduced to pre-experimental 
levels and healthy gingival conditions were reestablished. In addition, 
characteristic changes were observed in the bacterial flora during the 
6,7 
development of marginal gingivitis in these subjects. 
Subsequent studies have shown that specific microorganisms are found 
in the gingival sulcus in health and in various forms of periodontal dis-
4,5 
ease. Accordingly, the proportions of subgingival Gram-negative and 
4,5 
anaerobic organisms increase with the severity of periodontal disease. 
As a result of these studies, a rationale has been established for the 
use of antibiotics in the treatment of periodontal disease. Although 
many antibiotics have been investigated, tetracycline has received much 
8,9, 10 
attention in recent reviews. 
Of special importance is the fact that tetracycline hydrochloride 
8 
is effective against the majority of the periodontal pathogens. Orally 
administered tetracycline has also been shown to pass into the gingival 
11 
crevicular fluid in humans. In addition, minocycline hydrochloride, a 
1 
semi-synthetic tetracycline, can be given in lower doses than tetracy-
12 
cline hydrochloride and has been shown by Ciancio and coworkers to be 
2 
more concentrated in the gingival fluid than tetracycline and produces a 
reduction in subgingival plaque and gingival inflammation. Since the 
gingival crevicular fluid is in intimate contact with both the subgingival 
and supragingival microflora, this finding suggests that minocycline may 
12 
be more effective clinically than tetracycline. 
The purpose of this study is to compare a one week regimen of 
orally administered minocycline hydrochloride (Minocin) following scaling 
and root planing with scaling and root planing alone. The subgingival 
microbial population in selected periodontal pockets will be quantitated 
and qualitated by darkfield microscopy before and after treatment in five 
13 
human subjects with moderate periodontitis. In addition, probing depth 
14 
and Gingival Index, as clinical parameters, will be determined from 
15 
teeth numbers 3 and 19. 
CHAPTER II 
LITERATURE REVIEW 
A. THE ROLE OF BACTERIA IN THE PERIODONTAL DISEASES 
It has been well documented that bacteria are the primary etiologic 
1 ,2,3,4,5 
agents of the various forms of periodontal disease. In addition, 
studies have shown that specific microorganisms are found in the gingival 
crevice in health, and in the periodontal pockets associated with the dif-
4,5,16,17 5 
ferent forms of periodontal disease. Review articles by Slots 
4 
and Socransky summarize the specific groups of organisms that may be 
etiologically associated with specific forms of periodontal disease. 
The predominant cultivable microflora inhabiting the healthy gingi-
val sulcus include Gram-positive facultatively anaerobic cocci and rods 
such as Streptococcus sanguis, Streptococcus mitis, Actinomyces naeslundii 
and Actinomyces viscosus. In addition, Slots observed that 15.0% of the 
isolates from healthy gingival sulci were Gram-negative organisms. The 
genera identified included Veillonella, Neisseria, Bacteriodes, and Fuso-
5 
bacterium. 
In gingivitis, Gram-positive species predominated, but Gram-negative 
5 
organisms were prevalent. The Gram-positive organisms included Strep-
tococcus mitis, Streptococcus sanguis, Actinomyces israelii, A. Naes-
lundii, and A. viscosus. Moreover, Gram-negative anaerobic rods averaged 
25% of the cultivable organisms and included Fusobacterium nucleatum and 
3 
4 
5 
Bacteroides melaninogenicus ss. intermedius. Slots also found that Gram-
negative facultative anaerobic rods averaged nearly 15% of the cultivable 
5 
organisms and were identified as Haemophilus and Veillonella species. 
In advanced adult periodontitis, Gram-negative anaerobic rods are 
the most predominant organisms and include Bacteroides gingivalis, Bac-
teroides melaninogenicus ss. intermedius, Fusobacterium nucleatum, and 
5,8 
strains of the genera Selenomonas, and Campylobacter. Moreover, anaer-
obic vi bri os, 11 corrodi ng 11 Bacteroides and Ei ken a 11 a corrodens are found 
4 
in the destructive periodontitis pockets. Additionally, Slots found 
that the Gram-positive anaerobic and facultatively anaerobic rods account-
ed for about 19% of the isolates. The majority of these organisms were 
strains of Actinomyces israelii. 
As far as juvenile periodontitis (periodontosis) is concerned, the 
microbial composition of the pocket reveals the presence of a sparse mi-
crobiota which is predominated by Gram-negative capnophilic and anaerobic 
4 16 
rods. Evidence provided by Newman and Socransky subsequently lead to 
a significant number of isolates from the juvenile periodontitis pockets 
to be called Capnocytophaga. In addition, Tanner and coworkers isolated 
a Gram-negative organism with characteristics consistent with Actinobacil-
lus actinomycetemcomitans. The organisms were isolated from young adult 
subjects and were physiologically similar to strains isolated from perio-
17 
dontosis lesions. 
Listgarten, in a light and electron microscopic study of the struc-
ture of the microbial flora on tooth surfaces, also noted that a distinct 
5 
microbiota was associated with surfaces grouped according to their perio-
18 
dontal status prior to extraction. He found that the subgingival bac-
terial flora of the periodontitis samples consisted of relatively fewer 
cells adherent to the root surface as opposed to the supragingival bac-
terial deposits. Moreover, there was a concomitant increase in the popu-
lation of Gram-negative, flagellated cells, and spirochetes as compared 
18 
to the gingivitis samples. 
However, it must be noted that spirochetes, which account for over 
one third of the subgingival flora in a severely diseased site, are not 
detected by cultural methods in current use for assaying the composition 
of the oral flora. However, spirochetes can be morphologically determined 
19 
and quantitated by darkfield microscopy. 
19 
In a study by Listgarten and Hellden, they compared the relative 
distribution of bacteria from relatively normal and periodontally dis-
eased sites in twelve patients with advanced periodontal disease by dark-
field microscopy. In the 11 healthy 11 sites, coccoid cells were the pre-
dominant cell type along with straight rods, but spirochetes were rare. 
Conversely, the flora obtained from the 11 diseased 11 sites showed marked 
differences from that of the relatively healthy sites. That is, coccoid 
cells and rods constituted less than one half of the flora. As a result, 
spirochetes showed a marked increase both in prevalence and relative pro-
portions compared to the 11 healthy 11 sites. They were detected in all sub-
jects with periodontal disease in proportions ranging from 24.5 to 58% 
of the subgingival flora. In addition, the ratio of motile to nonmotile 
cells was 1:49 in the 11 healthy 11 samples, whereas in the diseased sites 
19 
this ratio was almost 1:1. 
Hence, these findings demonstrated clear-cut differences in the 
microbial composition of healthy and periodontally diseased areas in the 
6 
same individuals. Moreover, darkfield microscopy has been shown to be an 
effective tool in demonstrating distinct differences in the composition 
of the microbial flora taken from healthy sulci and periodontally diseased 
19 
pockets. 
In addition, the potential role of microorganisms as predictors of 
20,21,22,23 
disease activity has been studied by many investigators. These 
studies suggest that microorganisms associated with certain forms of peri-
odontal disease may be reduced in proportion to other organisms by therapy, 
then return to baseline levels prior to detectable deterioration of the 
23 
clinical status. 
23 
Recently, Listgarten and Levin showed that microbial proportions 
determined by darkfield microscopy appeared to provide much better dis-
crimination between disease-resistant subjects and disease-susceptible 
individuals as compared to clinical measurements. Their results also 
showed an excellent correlation between percentage spirochetes or per-
centage spirochetes and motile rods to human subjects susceptible to 
periodontal breakdown. 
In another differential darkfield microscopic study, Lindhe and co-
24 
workers reported that the sites of advanced disease were associated 
with a flora dominated by motile rods and spirochetes. Their observa-
tions would tend to support the hypothesis that a bacterial change pre-
cedes a change in the periodontal status rather than the other way around. 
7 
B. TETRACYCLINE IN THE TREATMENT OF ADULT PERIODONTAL DISEASE 
Based upon the concept that the periodontal diseases have a micro-
bial etiology, it is a logical hypothesis that antibiotics could effect 
a change in the composition of subgingival plaque if adequate levels can 
8,9 25 
be achieved in the gingival fluid and saliva. Furthermore, Loesche 
contends that plaque is not a single nondescript bacteriological entity 
as is postulated by the nonspecific plaque hypothesis (NSPH), but rather 
a series of microbial combinations, some of which are associated with 
clinical disease as is stated by the specific plaque hypothesis (SPH). 
In other words, the SPH states that only certain plaques cause infection, 
because of the presence of a pathogen(s) and/or a relative increase in 
the levels of certain indigenous plaque organisms. Moreover, the SPH 
requires that a diagnosis of infection be made so that prompt mechanical 
and/or chemical therapy can be initiated in order to restore the normal 
25 
plaque flora. 
Hence, an ideal antibiotic for use in the prevention and treatment 
of periodontal disease would be one that would act specifically on perio-
dontal pathogens, would not be allergenic or toxic, would maintain activ-
ity in the oral environment or tissue for long periods, would not be in 
general use for treatment of other disease, and would not be prohibitively 
9 
expensive. Accordingly, tetracycline hydrochloride, hereafter referred 
to as tetracycline, a broad spectrum antibiotic used in the treatment of 
acne vulgaris, has been shown to be inhibitory for bacteria currently im-
8,26 
plicated in destructive periodontal disease. Moreover, tetracycline 
has a low incidence of hypersensitivity and appears to be one of the 
8,9,27 
safest antibiotics because severe adverse effects are minimal. 
8 
However, tetracyclines are certainly not without side effects. Their 
adverse reactions include phototoxicity, oncholysis, allergic reaction, 
gastrointestinal symptoms including nausea, vomiting, proctitis, and glos-
sitis or stomatitis and staining of the teeth in young children if given 
during the last half of pregnancy or the first eight years of life. Other 
side effects include hepatic toxicity, Candida albicans superinfection, 
resistant staphylococci and Gram-negative bacilli, kidney effects such as 
azotemia, and the Fanconi syndrome associated with the use of outdated 
tetracycline. Moreover, tetracyclines may lead to delayed fontanelle 
closure with increased intracranial pressure in children and their use 
8,27,28,29 
should be avoided during pregnancy. 
29 
In a review by Ciancio, it was found that tetracyclines may alter 
the production by microorganisms and the absorption of vitamin K in the 
gastrointestinal tract. Therefore, since vitamin K is important in the 
formation of prothrombin in the liver, an interaction with oral anticoag-
ulants can be expected. 
As far as antibacterial activity is concerned, the tetracyclines 
are effective against both Gram-positive and Gram-negative organisms 
28,29 
both aerobic and anaerobic species. These compounds are bacteria-
static in that they are taken up by the cell and interfere with protein 
synthesis at the 305 ribosomal level. However, if the bacterium is in 
an area in which there is no further DNA, RNA, or protein synthesis and 
the bacterium is not phagocytosed, the organism can subsequently start 
growing again if the tetracycline leaks out of the cell. This is possible 
28 
because tetracyclines are not permanently bound to ribosomes. 
9 
In terms of efficacy, the tetracyclines have proved useful in a 
variety of unusual infections. These include the rickettsial and chlamy-
dial infections as well as brucellosis, tularemia and mycoplasma pneu-
monia. Relapsing fever caused by Borrelia, melioidosis, and cholera are 
28,29 
less common, but, again the tetracyclines are the drugs of choice. 
In recent years, there have been numerous clinical, microbiological 
and histological studies of the effect of tetracycline on human perio-
20,21,30,31,32,33,34,56 
dontal disease. In a much earlier study, it was 
35 
shown by Loe and coworkers that a 0.5% mouth rinse of tetracycline used 
for five days by subjects who ceased all oral hygiene measures, resulted 
in a pronounced reduction of the gingival bacterial flora. 
Most of the recent studies however, have used systemically admin-
istered tetracycline in the treatment of adult periodontitis. In a study 
30 
by Genco et al., it was shown that the use of tetracycline as an ad-
junct in periodontal therapy significantly enhances healing. Moreover, 
31 
Reynolds and coworkers reported that changes in the subgingival flora 
were different and longer lasting in the tetracycline group than those 
occurring with mechanical therapy alone, and may have been related to the 
better clinical results observed in the tetracycline group. 
Of special importance in considering the pharmacodynamics of anti-
biotics to be used in periodontal therapy is the concentration of the 
8 
active drug which reaches the periodontal microflora. This concentra-
tion can be estimated by studying the antibiotic levels in gingival 
8,11,36 
fluid. Since this exudate seems to be a characteristic feature of 
10 
gingival inflammation, one could reasonably expect that suitable drugs 
could be given to a patient and carried from the general circulation to 
36 
the pathological gingival tissue by the flow of gingival fluid. 
Accordingly, tetracycline has been shown to pass into the gingival 
11,37 37 
crevicular fluid in man. When Ciancio et al., quantitated the 
amount of tetracycline in human gingival fluid they found that tetracy-
cline was measurable in eleven of the fourteen crevices sampled. In ad-
dition, the gingival fluid concentration of tetracycline hydrochloride 
was up to ten times greater than the serum concentration in the twelfth 
week of drug administration. 
38 
Furthermore, studies by Gordon and coworkers reported that the 
levels of tetracycline in gingival fluid were two to ten times blood lev-
els after a single oral dose of either 250 mg or 500 mg. Using the same 
sensitive bioassay after oral administration of repeated 250 mg doses of 
39 
tetracycline, the same investigators demonstrated that the crevicular 
fluid levels of tetracycline were typically two to four times the blood 
39 
levels. In the repeated dosage study, volunteers given 250 mg of tetra-
cycline hydrochloride every six hours had average crevicular fluid con-
centrations between four to eight micrograms per milliliter and blood 
concentrations between two to two and one half micrograms per milliliter. 
Consequently, significantly higher concentrations of tetracycline in the 
gingival fluid as compared to blood may alter dosage and administration 
schedules of the antibiotic as well as affect the clinical efficacy of 
39 
the antibiotic in periodontal therapy. 
As a result of these studies, the antimicrobial activity of 
11 
tetracycline on subgingival organisms was investigated by Walker and co-
26 
workers. In an~ vitro study, they compared the susceptibility of 
the bacteria associated with periodontal disease to tetracycline levels 
achieved at the infection site. Minimum inhibitory concentrations (MICs) 
were determined using tetracycline by an agar dilution technique. The 
MIC was defined as the lowest concentration of the antibiotic that gave 
26 
no growth. With the exception of the streptococci and a few strains of 
lactobacilli, most isolates examined were inhibited by four to eight mi-
26 
crograms per milliliter of tetracycline. 
39 
As a result of the study by Gordon et al., four to eight micro-
grams per milliliter is the concentration of the drug that can be ex-
pected in crevicular fluid following oral administration of one gram per 
day. However, there is a limitation to these in vitro studies. Namely, 
spirochetes are presently not cultivable and hence, cannot be tested in 
8 
vitro. 
Although recent interest has focused on the local delivery of tetra-
40,41,42,57 
cycline with the use of hollow fiber devices, the subsequent re-
view will concern itself with systemically administered tetracycline. 
20 
Correspondingly, Listgarten and coworkers studied the effect of tetra-
cycline and/or scaling on 12 adult periodontitis patients for 25 weeks. 
Six subjects received one gram per day of tetracycline during weeks one 
and two, and again during weeks seven and eight, while the others did 
not. Moreover, all subjects were scaled and root planed on only one side 
of their dentition, and all were instructed in oral hygiene. 
12 
The results of this study showed that in the tetracycline-treated 
patients, sites which were scaled showed changes in the clinical, micro-
biological and histological parameters that were similar to changes seen 
in the scaled sites in the nontetracycline-treated patients at all inter-
vals. However, in the presence of the antibiotic the eighth week propor-
tions of coccoid cells were higher and those for motile rods and spiro-
chetes lower. Furthermore, the sites that were not scaled in the tetra-
cycline-treated patients showed improvement in the clinical and micro-
biological parameters at eight weeks, but at 25 weeks the microbial com-
position showed a significant rebound toward the values observed at base-
20 
line. 
In a subsequent report on the same patient groups, Hellden, List-
32 
garten and Lindhe showed that the only beneficial effect of tetracycline 
was significant gains in the attachment level in the tetracycline-treated 
patients between the zero-week and 25-week examinations. However, the 
clinical significance of the results obtained is unclear since the magni-
tude of the gain of attachment was very small. However, their results did 
30 
agree with Genco et al., in that tetracycline as an adjunct in perio-
dontal therapy significantly enhances healing. 
43 
In a recent case report, Osterberg and others studied the long-
term effects of tetracycline on the subgingival microflora in a 33 year 
old female with advanced periodontitis. In this study, 1000 mg per day 
of tetracycline was administered orally for 14 days followed by 500 mg per 
day for 14 days. Within the scope of this investigation, it was noted 
13 
that small spirochetes had begun to recolonize 16 weeks after therapy but 
Bacteroides asaccharolyticus and the 11 corroding 11 anaerobic rods remained· 
inconspicuous. In addition, many of the Gram-positive cocci isolated 
during treatment had high levels of resistance to tetracycline. 
34 
In a subsequent study by the same investigators, samples of sub-
gingival plaque were collected from periodontal patients receiving two 
different tetracycline regimens following conventional periodontal thera-
py. In this study, four patients received 1000 mg/day for 14 days and 
nine patients received 1000 mg/day for one week followed by 250 mg/day 
for extended time periods (21-114 days). For both treatment groups, 
Streptococci and the branching, filamentous Gram-positive rods, Actina-
myces and Rothia were the predominant organisms cultured. However, the 
microflora of the group receiving 250 mg a day had a greater complexity 
and included many fastidious Gram-negative organisms presently implicated 
in the etiology of periodontal disease. Therefore, it was concluded that 
the prolonged lower dose treatment was no more effective than the two 
week, 1000 mg/day treatment and that it resulted in the generation of 
34 
greater numbers of tetracycline resistant organisms. 
Accordingly, bacterial resistance demonstrates the need for criti-
34,43,44 
cal evaluation of the long term, low dose use of tetracycline. 
Transmission of antibiotic resistance among bacterial strains, mediated 
by extrachromosomal DNA molecules called plasmids, is most frequently 
34 
encountered in association with the continual presence of tetracycline. 
These plasmids, or R-factors, may carry resistance genes for nearly all 
45,46 
the known antibiotics. 
Antibiotic resistance then, is transferred from one bacterium to 
another by the process of conjugation which requires close contact be-
46 
tween bacteria. R plasmid-tetracycline resistance is often the re-
14 
sult of a new active transport system that "pumps 11 the drug out of the 
cell so as to prevent it from accumulating intracellularly and inhibiting 
8 
growth. Hence, antimicrobial therapeutic approaches, such as systemi-
cally administered tetracycline for the treatment of periodontal disease, 
must be tempered with knowledge of the risks associated with the spread 
8 
of bacterial drug resistance. 
In another microbiological and clinical study of six periodontitis 
21 
patients, Slots and coworkers investigated the kinetics of repopulation 
of the periodontal microflora after a single course of scaling and root 
planing and by the adjunctive systemic use of tetracycline. A main find-
ing of this six month study was the demonstration of major differences in 
the composition of the pre- and post-treatment subgingival flora. Fur-
thermore, the most pronounced and long lasting differences were found with 
the total number of organisms and the proportion of spirochetes, both of 
which were markedly reduced in most pockets after therapy as monitored 
by phase contrast microscopy. 
In their study, major adjunctive effects of tetracycline on the sub-
gingival flora were not seen. However, there was a more consistent and 
earlier reduction in the Gram-negative anaerobic organisms with the use 
of tetracycline as compared to conventional therapy alone. Of possible 
15 
significance however, were the effects of tetracycline observed in the 
two 11 refractory 11 patients in whom reduction of the flora was not achieved 
by repeated conventional therapy. A distinct reduction in the gingival 
microflora and a clinical improvement in soft tissue inflammation were 
found in both patients after systemic administration of tetracycline. 
21 
21 
From these results, Slots and coworkers proposed a model for the 
treatment of periodontal disease consisting of the following three steps: 
(1) conventional therapy including thorough periodontal scaling and root 
planing; (2) monitoring the subgingival flora and the clinical course; 
and (3) use of antimicrobial therapy in refractory cases when an adequate 
microbiological subgingival and/or clinical response is not taking place. 
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In a more recent double-blind crossover study, Scopp et al., com~ 
pared a group of patients treated with conventional therapy and adjunc-
tive tetracycline to a group treated with conventional therapy alone. At 
the end of three months, the groups were switched and the study was re-
peated for an additional three months. Although microbiological para-
meters were not studied, their data suggested that adjunctive tetracycline 
therapy does not appreciably alter either the Gingival Index, Debris In-
dex, or the Papillary Bleeding Index as compared to that achieved by oral 
hygiene instruction and root planing alone. 
C. MINOCYCLINE IN THE TREATMENT OF ADULT PERIODONTAL DISEASE 
Minocycline hydrochloride, hereafter referred to as minocycline, is 
a semi-synthetic derivative of tetracycline. Introduced in 1967, it is 
chemically known as 7-dimethylamino-6-deoxy-6-demethyltetracycline 
8,12,27,28 
hydrochloride. 
Like its parent compound, minocycline is primarily bacteriostatic 
16 
and exerts its antimicrobial effect by the inhibition of protein synthesis. 
Accordingly, minocycline has antibacterial activity against a wide range 
of Gram-negative and Gram-positive organisms. In addition, it is effec-
tive against staphylococci, particularly those resistant to other tetra-
12,28 
cyclines such as S. aureus. 
Pharmacologically, minocycline has a longer serum half life (17-20 
hours) and a lower urinary excretion rate than most other tetracyclines. 
Those characteristics permit the use of smaller and less frequent doses. 
Minocycline reaches a greater concentration in tears and saliva, due to 
12,27,47 
its increased solubility in lipid, than other tetracyclines. 
Additionally, minocycline is. well absorbed from the stomach and 
upper small intestine. More specifically, food and dairy products that 
contain calcium do not interfere with its absorption, as in the case with 
tetracycline. However, the absorption of all oral tetracyclines is im-
paired by the concomitant administration of antacids containing divalent 
27,28 
cations (aluminum, calcium, magnesium) and iron preparations. The 
mechanisms responsible for the decreased absorption appear to be chela-
27 
tion and an increase in gastric pH. 
Regarding excretion, minocycline is recoverable both from urine and 
feces in significantly lower amounts than are the other tetracyclines. It 
appears to be metabolized to a considerable extent and hence, renal clear-
ance is low. Moreover, minocycline persists in the body after its 
administration is stopped, most likely due to retention in fatty tis-
27 
sues. 
17 
As reported earlier, side effects associated with tetracycline ther-
28,29 
apy are varied. However, minocycline shows less phototoxicity and 
8 
less renal toxicity as compared to tetracycline. Conversely, patients 
receiving minocycline may experience vestibular toxicity, characterized 
8,27,28 by dizziness, ataxia, nausea, and vomiting. Those symptoms occur 
soon after the initial dose and generally disappear within 24-48 hours 
after drug administration is stopped. The frequency of this side effect 
is directly related to the dose and has been noted more often in women 
12,27 
than in men. 
12,48,49 
Recently, there have been numerous studies evaluating min-
ocycline in the treatment of human periodontal disease. Ciancio and 
12,50 
others have shown that minocycline is concentrated in gingival crev-
icular fluid at much higher levels than in serum and saliva. The mech-
anism responsible for the elevated levels of oral tetracyclines, including 
minocycline, in gingival fluid is presently not known, but may be related 
36 
to the elevated calcium content of gingival fluid. Accordingly, the 
elevated concentration of minocycline in gingival crevicular fluid must 
be considered when determining the antibiotic susceptibility of the micro-
biota inhabiting the periodontal pocket. 
12 
In one study, Ciancio et al., determined the passage and con-
centration of minocycline in gingival crevicular fluid (GCF), and the re-
lationship between its concentration in saliva, GCF, serum and changes in 
18 
periodontal health. Over an eight day period, a group of patients with 
gingivitis and/or periodontitis was given either 200 mg (Group 1) or 
150 mg (Group 2) per day of minocycline (Minocin). The results of the 
study showed that Minocin administration resulted in no significant 
changes in blood chemistry, blood counts and prothrombin time, and was 
effective against oral microorganisms as shown by decreased Gingival and 
Plaque Index scores. 
In addition, it was determined that the concentration of minocycline 
in saliva is far below that in serum, and the concentration in GCF is at 
levels five times as high as serum. Over the eight days, the GCF concen-
trations ranged from 3.98 ± 0.62 to 15.89 ± 3.12 ~g/ml, while the blood 
concentrations ranged from 1.02 ± 0.10 to 3.26 ± 0.30 ~g/ml. Since the 
concentration of minocycline in serum remained in the bacteriostatic range 
(above l ~g/ml) in both dosage groups, a dose of 150 mg per day should be 
12 
adequate for use in dental patients. Moreover, vertigo was reported in 
four of nine patients in Group l but not in Group 2. No other adverse 
12 
side effects were reported or observed in this study. 
In a subsequent clinical and microbiological study, Ciancio and co-
48 
workers compared minocycline to a placebo concomitant with half mouth 
scaling and root planing in 26 periodontitis patients. By phase contrast 
microscope monitoring of the subgingival flora, all the minocycline pa-
tients had marked reductions in total bacterial counts and complete elim-
ination of spirochetes for periods up to two months. Moreover, the clin-
ical parameters were reduced after antibiotic therapy, especially on the 
scaled side. 
19 
49 
Reynolds et al., in an in vitro study, compared minimal inhibi-
tory concentrations (MICs) of minocycline with 25 other antimicrobial 
agents. In all test strains of Bacteroides gingivalis, Bacteroides 
melaninogenicus subspecies, Fusobacterium nucleatum, Capnocytophaga and 
Actinomyces, the MIC values for minocycline were maximally 1 ~g/ml. 
Moreover, several strains exhibited much lower MIC values for minocycline 
than for other tetracyclines. Hence, minocycline is highly active against 
49 
most periodontopathic organisms. 
51 
Finally, in a case report by Bartolucci and Parkes, minocycline 
was used adjunctively in the hygienic phase of periodontal treatment in 
an uncontrolled diabetic. Minocin in a dose of 150 mg/day was prescribed 
for two cycles of eight days each, separated by an interval of three 
weeks. The authors felt that Minocin, when used as an adjunct to scaling 
and root planing, contributed to the success of the initial periodontal 
therapy in this systemically compromised patient. 
CHAPTER III 
MATERIALS AND METHODS 
A. SELECTION OF PATIENTS 
Six adult human subjects~ two females and four males, ranging in 
age from 36 to 48 years were selected for this study. Those patients 
will hereafter be referred to as JK, BM, BP, BF, RS or TS. They were 
diagnosed as having Type III moderate periodontitis according to the 
52 
American Academy of Periodontology's definition of case types. Five of 
the subjects had no antibiotic therapy or scaling within the previous 
four months. One of the patients, BP, had a prophylaxis four months pre-
vious to her participation in the study. In addition, she completed a 
seven day regime of erythromycin (1 gm/day) for the treatment of pneu-
monia two months prior to her involvement in this study. She was in-
eluded in the study because she had an abundance of subgingival plaque 
and met the other diagnostic criteria. 
To participate in the study~ the patients were required to have 
teeth numbers 3 (maxillary right first molar) and 19 (mandibular left 
first molar). They were selected because they were among the represen-
15,53 
tative teeth determined by Ramfjord to provide an accurate assess-
ment of the periodontal status of an individual. In addition, these 
teeth must have been in at least mesial contact with an adjacent tooth in 
order that an interproximal periodontal pocket could be studied. 
20 
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Each subject received an oral written explanation of the study and 
was asked to sign a consent form (Fig. 1). This study was reviewed by 
the Loyola University Medical Center Institutional Review Board (IRB) for 
the Protection of Human Subjects and was approved prior to the initiation 
of the study. 
The control group A consisted of two subjects, BF (Table 1) and TS, 
who did not take the drug. The experimental group B consisted of three 
subjects, JK, BM and BP (Table 1), each of whom requested to take the 
antibiotic, minocycline. The sixth subject, RS, started in the control 
group but finished as experimental group C. The experimental group C 
became necessary when that patient underwent penicillin therapy for an 
acute periodontal abscess during the experimental period. Before commenc-
ing the study, the three subjects in the experimental groups received a 
sequential multiple analysis (SMA-24) and a complete blood count with dif-
ferential. In all cases the laboratory results were unremarkable and 
within normal limits. Moreover, none of the patients had a history of 
hepatitis or liver disease, rheumatic fever, renal impairment, or hyper-
sensitivity to any of the tetracyclines. The two females in the study 
were neither pregnant nor lactating. 
Although six subjects agreed to participate in the experiment, five 
completed it. One of the male patients in the control group, TS, with-
drew from the study two months after baseline measurements were obtained 
due to lack of interest. 
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B. EXPERIMENTAL DESIGN 
The subjects in both groups (control and experimental) had initial 
clinical and microbiological measurements taken from teeth numbers 3 and 
19 to establish a baseline (Table 1). Subsequently, the five patients 
were each given oral hygiene instructions and full mouth scaling and root 
planing during several appointments. Two to three weeks after the hy-
giene phase (Day 0), both groups again had clinical and microbiological 
measurements taken. On Day l, the three subjects in the experimental 
group B began taking a seven day regimen of minocycline {Minocin, Lederle 
Laboratories Div., American Cyanamid Co., Pearl River, N.Y.). This seven 
54 
day Minocin regime consisted of 50 mg in the morning and 100 mg in the 
evening. During this time, the control group A practiced oral hygiene 
only. Selected sites from teeth numbers 3 and 19 were monitored clini-
cally and microbiologically for nine weeks from Day 0 in Groups A and B. 
The clinical parameters studied were the Gingival Index (GI), of 
14,55 
Loe and Silness, to assess the qualitative changes in the gingival 
13 
soft tissue and the probing depth measured from the gingival margin of 
selected periodontal pockets. In the Gingival Index, each of the four 
gingival areas of the tooth is given a score from zero to three. The 
scores from the four areas of the tooth are added and divided by four to 
give the GI for the tooth. Table 2 gives the criteria for this index 
14 
system. 
14 
Table 2. Criteria for the Gingival Index System. 
0 = Normal gingiva 
l =Mild inflammation - slight change in color, slight edema, 
no bleeding on probing 
2 = Moderate inflammation redness, edema, glazing, bleeding 
on probing 
3 = Severe inflammation - marked redness, edema, ulceration, 
tendency to spontaneous bleeding 
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The probing depth of the periodontal pockets was measured with a 
calibrated University of Michigan #0 probe (Hu-Friedy Manufacturing Corp., 
Chicago, IL.). The probe had graduated markings at each millimeter ex-
cept the fourth and sixth millimeter position. The probing depth was 
measured from the gingival margin to the bottom of the periodontal pocket 
and always at the same site at each tooth. Measuring the probing depth 
rather than the sulcus or pocket depth is consistent with the studies of 
Listgarten. Moreover, investigations on the histopathology of the perio-
dontal lesion and the histological features of the healing lesion, to-
gether with histological studies on the relationship of the probe to 
periodontal tissues, have shed new light on periodontal probing. In ac-
cordance with studies by Listgarten, probing depth measured from the gin-
gival margin seldom corresponds to sulcus or pocket depth. The discrep-
ancy decreases in the absence of inflammatory changes and increases with 
13 
increasing degrees of inflammation. 
The microbiological parameters studied were the qualitative and 
quantitative measurements of microbial forms obtained by darkfield 
24 
microscopic examination of plaque samples from selected periodontal poc-
kets associated with teeth numbers 3 and 19. Figure 2 gives a schematic 
summary of the experimental design. 
C. MICROBIOLOGICAL PROCEDURES 
The subgingival microflora was monitored by darkfield microscopy 
subsequent to obtaining a two microliter plaque sample from each perio-
dontal pocket. The two periodontal pockets selected per patient included 
one from tooth number 3 and one from tooth number 19. 
Before obtaining a plaque sample however, a sampling device had to 
be prepared. It consisted of a five microliter Hamilton syringe (Hamilton 
Co., Reno, Nev.) with a blunted tip to which a two microliter capillary 
tube (Micro Pipets, Curtin Matheson Scientific, Inc. Houston, Tx.) was 
affixed with heat shrinkable tubing. Next, two microliters of sterile 
heparinized water (5 USP units heparin sodium per 1 ml water) were drawn 
into the syringe. A stream of air into the attached capillary tube kept 
it empty and dry. 
The tip end of the sampling device was then inserted into the perio-
dontal pocket of the tooth under study. The two microliters of sterile 
heparinized water were slowly injected from the syringe into the pocket 
while the tip was moved carefully in all directions. During this time 
the capillary tube should have filled completely due to capillary attrac-
tion. The subgingival fluid sample contained microorganisms that in-
habited the periodontal pocket. 
Subsequently, the two microliter sample was dispersed by a modified 
25 
eye dropper (Curtin Matheson Scientific, Inc. Houston, Tx.) on to a plain 
microscopic slide (Scientific Products, McGaw Park, IL.) and mixed with 
an additional three microliters of heparinized water. A cover glass 
(Scientific Products, McGaw Park, IL.) was then placed over the five 
microliter mixture and its edges were sealed with paraffin. 
Next, the slide was focused under a darkfield microscope (Balplan 
Microscope, Bausch & Lomb Inc., Rochester, N.Y.) utilizing a lOOX objec-
tive lens and a lOX wide field eyepiece on oil immersion. As each slide 
was examined by darkfield microscopy at a magnification of lOOOX, the 
organisms were enumerated from randomly selected microscopic fields. In 
each field, the organisms were counted according to the following morpho-
logic groups: spirochetes (small, medium, large), motile rods (small, 
large, curved), and non-motile organisms (short rods, cocci, fusiforms 
19 
and filaments) (Figure 3). The counting continued until either 12 
fields were examined or at least 100 organisms were counted, whichever 
came first. Any observed neutrophils were counted but did not enter into 
the total microbial count. 
Upon completion of the data collection, the raw microbial counts 
per number of fields were converted into the actual microbial counts per 
microliter by calculations made on a 3033-S IBM computer. The counts per 
microliter were plotted against the time period of the study by an S-100 
microcomputer with a Hi-Plot DPM-3 plotter (Houston Instruments, Houston, 
Tx.) according to the following microbial groups: spirochetes, motile 
rods, and the combined non-motile organisms. Figure 4 lists and 
interprets the darkfield microscopic calculations made to determine the 
80 
microbial counts per microliter of those groups. 
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CHAPTER IV 
RESULTS 
A. CLINICAL PARAMETERS 
The effect of scaling and root planing on the Gingival Index (GI) 
and probing depth (PO) is shown for the single completed patient in the 
control group A, B.F., in Table 3 and Figures 5 and 6. Although both clin-
ical parameters decreased after scaling and root planing, the PO reduc-
tion was more pronounced at the completion of the study. The GI tended 
to return to pre-scaling levels by week nine for both teeth numbers 3 
and 19. 
The effect of scaling and root planing and a one week regimen of 
minocycline (Minocin) on the GI and PO is presented in Tables 4-6 and 
Figures 7-12 for the patients in the experimental group B, J.K., B.M. and 
B.P. The GI dropped noticeably subsequent to the minocycline regime in 
all patients. The GI for J.K. returned to pre-treatment levels by week 
eight. However, the post-Minocin GI scores for B.M. and B.P. remained 
lower than the pre-scaling scores throughout the experimental period. 
The PO, as measured in the same experimental group, was reduced in 
four out of six periodontal pockets after the seven day Minocin regimes. 
In addition, three of these four PO measurements remained below the post-
scaling levels throughout the experimental period. One of the post-
scaling pocket depths of B.M. remained at a constant level throughout 
27 
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the term of the study. In only one instance, a PO of subject J.K., was 
the final PO level greater than the day zero PO level. 
The fifth subject, R.S., started in the control group, but finished 
as experimental group C. At the completion of the scaling and root plan-
ing phase, R.S. took 500 mg of penicillin (V-Cillin K, Eli Lilly and Co., 
Indianapolis, In.) orally every six hours for five days for treatment of 
a lateral periodontal abscess associated with tooth number 14. Two weeks 
later, he commenced a second oral regime of penicillin for treatment of 
a palatal space abscess adjacent to the extraction site of tooth number 
15. 
It was during that second regimen of 250 mg of penicillin every 
six hours for seven days that coincided with week one of the experimental 
period. For that reason, R.S. continued participation in the study so 
that the adjunctive effect of penicillin could be monitored clinically 
and microbiologically. Table 7 and Figures 13-14 show the effect of 
scaling and root planing and two oral regimes of penicillin on the GI 
and PO for R.S. 
The results of the experimental group C show a noticeable drop in 
both the GI and PO after the second regime of penicillin. The GI scores 
for both teeth stayed below the pre-treatment levels through week nine. 
Conversely, the PO levels returned to the pre-scaling and root planing 
measurements for both periodontal pockets by week eight. 
B. MICROBIOLOGICAL PARAMETERS 
The effect of scaling and root planing on the counts/~1 of 
29 
spirochetes, motile rods and non-motile forms of the two selected perio-
dontal pockets in the single control group A patient, B.F., is shown in 
Tables 8-9 and Figures 15-16. The spirochetes in both pockets were re-
duced to zero after scaling, root planing and oral hygiene. However, 
an increase in the spirochete levels of both pockets was evident by 
week four. In the pocket associated with tooth number 19, the spiro-
chete count returned to zero at week eight before exceeding the pre-
scaling count at week nine. In addition. the motile rods decreased notice-
ably after treatment in both pockets but exceeded the day zero counts by 
week four. Conversely, the non-motile forms tended to increase in both 
periodontal pockets between weeks one and eight. 
In the experimental group B, the microbial counts/~l for the pa-
tients J.K., B.M. and B.P are shown in Tables 10-15 and Figures 17-22. 
In each pocket the spirochetes were dramatically reduced after the 
Minocin regime. Moreover, in three of the six pockets they were totally 
eliminated by week one. The spirochetes/~1 in four of the six pockets 
remained below the pre-treatment counts at the completion of the study. 
The spirochetes in the two remaining pockets in patients J.K. and B.P. 
eventually exceeded the pre-scaling spirochete counts by weeks eight and 
nine respectively. 
In the same experimental group, the motile rods also decreased in 
number in all six pockets following the seven day minocycline regimen. 
In J.K. and B.M. the post-antibiotic motile rods/~1 remained below the 
post-scaling counts at weeks four and nine respectively. In contrast, 
the post-Minocin motile rod counts in B.P. exceeded the post-scaling 
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counts at week four. The non-motile forms also decreased after the anti-
biotic administration in five of those six periodontal pockets, but to a 
much lesser degree than that of the spirochetes. In addition, the non-
motile form counts/~l were noticeably lower than either the spirochetes 
or the motile rods when the study was completed. 
The microorganism counts/~l in the experimental group C, for the 
single patient R.S., are shown in Tables 16-17 and Figures 23-24. All 
organisms were shown to decrease at week one but the effect of penicillin, 
scaling and root planing was less pronounced on the spirochetes. The 
spirochetes/~l in both pockets exceeded their post-scaling counts at week 
four, whereas the total non-motile forms/~l did not exceed their post-
scaling counts until week eight. The motile rod counts returned to their 
post-scaling levels in the pockets associated with teeth numbers 3 and 
19 by weeks eight and four respectively. 
Neutrophils were also counted from the plaque samples but their 
raw counts were not converted into actual counts/~1. Table 18 gives the 
neutrophil count of each plaque sample obtained from the five subjects 
in groups A, B and C during the time of the study. No noticeable trends 
could be observed from the sparse and intermittent neutrophil count. 
CHAPTER V 
DISCUSSION 
The present investigation demonstrated that in five patients with 
moderate periodontitis, treatment that consisted of either oral hygiene 
instruction and scaling and root planing alone or in combination with 
orally administered minocycline or penicillin, resulted in a decrease in 
the nine week post-treatment GI and PO of selected periodontal pockets 
associated with teeth numbers 3 and 19. It was also demonstrated that 
these treatment modalities had quantitative and qualitative effects on 
the subgingival microbial flora associated with the selected periodontal 
pockets. 
Because of the small sample size, statistics were not utilized in 
this investigation. Furthermore, statistics should be applied with great 
caution to clinical material where the basic data are dependent upon the 
ability of the examiner to observe, assess, and record rather subtle 
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clinical variation. Such subtleties appear to apply to the results of 
the clinical and microbiological parameters utilized in this study. 
The observed post-treatment Gingival Index scores were higher in 
this investigation than those found in other comparable studies. For 
20 
example, in the study by Listgarten and coworkers the observed median 
GI scores at 8 and 25 weeks were 0.5 and 0 respectively for both the 
scaling and the scaling and tetracycline groups. In another study, 
31 
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12 
Ciancio et al. reported reduced mean GI scores during an eight day Min-
ocin regime that did not include scaling and root planing. The mean GI 
score at day 8 was 1 .16. 
The sampling technique utilized in this study has confirmed the 
subgingival microbial repopulation of selected periodontal pockets. In 
their research, Hoerman and Hryhorczuk found consistent repopulation pat-
terns by the subgingival microbial flora nine weeks after scaling and root 
planing selected periodontal pockets. Utilizing this sampling technique 
whereby a standard volume is secured in a micropipet and diluted to a 
81 
standard volume, they collected over 250 samples in 30 patients. 
The decrease in gingival inflammation and probing depths in the 
control group A patient, B.F., after oral hygiene instruction, scaling 
and root planing is in agreement with several studies. More specifically, 
59 
Lovdal and coworkers found that the combined effect of subgingival 
scaling and controlled oral hygiene reduced the incidence of gingivitis. 
60 
In 1975, Tagge et al. conducted an eight week study evaluating the 
soft tissue response of suprabony periodontal pockets treated by root 
planing and oral hygiene or by oral hygiene measures alone. They found 
that root planing accompanied by oral hygiene reduced the mean pocket 
depth and the incidence and severity of gingivitis more than oral hy-
61 
giene measures alone. More recent studies by Morrison et al ., Hill et 
62 63 
al., and Lindhe and coworkers have shown that scaling, root planing 
and oral hygiene instruction resulted in reduced probing depth and gingi-
val inflammation. Morrison et al ., found that for pockets 7 mm or 
greater, the mean reduction was 2.22 ± 1.35 mm (P < .0001) one month 
following the hygienic phase of periodontal therapy. 
33 
The decrease in the GI scores and probing depths after the seven 
day Minocin regime in the experimental group B confirm data presented by 
12 
Ciancio and coworkers in 1980. In a subsequent investigation, Ciancio 
48 
et al. confirmed their earlier study and found that minocycline signi-
ficantly reduced the GI scores in 13 periodontitis patients with or with-
out scaling and root planing. The findings in the present study are 
20 
also in accordance with the 1978 investigation by Listgarten et al. 
Their results from the scaling and tetracycline sites showed decreased 
GI scores and reduced probing depths after 8 and 25 weeks. It should be 
noted that none of the experimental group B patients experienced any 
adverse reactions to Minocin. 
In experimental group C, R.S. had reduced clinical parameters 
after penicillin administration. But, the PD reduction was not as long-
lasting as that experienced by experimental group B after minocycline 
administration. Since the penicillin was taken systemically, some en-
25 
tered the oral cavity via saliva and/or gingival crevice. The reduced 
post-penicillin GI scores observed in patient R.F. are in contrast to 
64 
the observations of Pendrill and Reddy. They studied the efficacy of 
prophylactic penicillin taken for five days by patients who had under-
gone periodontal surgery. Throughout the four week study there was no 
statistical difference between the GI scores for the penicillin and 
placebo groups. 
34 
As antimicrobial agents, the penicillins are one of the most im-
portant of the antibiotics. Their basic structure consists of a thia-
zolidine ring connected to a beta-lactam ring, to which is attached a 
side chain R. The beta-lactam antibiotics can kill susceptible bacteria 
by inhibition of peptidoglycan synthesis. Peptidoglycan is a heteropoly-
meric component or the cell wall that provides rigid mechanical stabili-
ty by virtue of its highly cross-linked latticework structure. Moreover, 
the cell walls of bacteria are essential for their normal growth and de-
65 
velopment. 
In the present investigation, R.S. took penicillin V, the acid-
stable congener of penicillin G. Its antimicrobial spectrum includes 
Streptococcus species, Neisseria species, many anaerobes and spirochetes. 
However, penicillin G and its phenoxymethyl derivative, penicillin V, 
are hydrolyzed by staphylococcal penicillinase. After oral ingestion, 
penicillin V escapes destruction in gastric juice, since it is both in-
soluble and stable at a low pH. It goes into solution in the more al-
kaline medium of the duodenum and is well but incompletely absorbed from 
the upper portion of the small intestine. The peak concentration in the 
blood of an adult after an oral dose of 500 mg is nearly 3 ~g/ml. Once 
absorbed, penicillin V is distributed in the body and excreted by the 
kidney. Because penicillin V is rapidly eliminated, its half-life in 
the body is typically between 30 to 60 minutes and its concentration in 
65 
urine is high. 
Hypersensitivity reactions are by far the most common adverse 
effects noted with the penicillins. Although they are relatively non-
8,65 
toxic, a large percentage of the population is allergic to them. 
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Unquestionably, penicillin is the drug of choice when a potent bacteri-
cidal agent is required. However, the therapist must always remember 
that penicillin is the most allergenic drug in current use and should 
never be used arbitrarily. Its use should be selected only on the basis 
66 
of an established need for penicillin. In the present investigation 
R.S. did not experience any hypersensitivity or toxicity to penicillin V. 
The effectiveness of scaling alone or in combination with minocy-
cline on the microbiological parameters was assessed by monitoring the 
microbial repopulation kinetics of the subgingival area by darkfield 
microscopy. In the control group A patient, B.F., the spirochete and 
motile rod counts were noticeably reduced after scaling and root planing. 
These results are 
21 
Slots et al. 
20 
in agreement with the findings of Listgarten et al. 
22 
and Mousques et al. Those studies showed that mechanical 
debridement can produce a relatively long-lasting alteration in certain 
microbial proportions, and that the microbial proportions are shifted 
from those generally associated with untreated periodontal defects to-
19,24 
ward those seen at periodontally healthy sites. In patient B.F., 
the spirochetes/~l did not return to the pre-treatment level by week nine 
in the periodontal pocket associated with tooth number 3. However, the 
spirochete counts/~1 exceeded the pre-treatment level by the completion 
of the study in the periodontal pocket associated with tooth number 19. 
These spirochete shifts follow similar patterns in other studies. Slots 
36 
21 
et al. found that the proportions of spirochetes did not reach their 
22 
pre-treatment levels even after six months, whereas Mousques et al. 
reported a return to baseline levels by day 42. 
Moreover, there was a tendency for the GI scores and PO measure-
ments in B.F. to vary directly with the counts/~1 of spirochetes or 
motile rods. These findings confirm data reported by Rosenberg and co-
67 
workers in 1981. In general, they found that the GI and Pli (Plaque 
Index) scores and PO measurements varied directly with the proportions 
of spirochetes or motile rods after scaling and root planing. In patient 
B.F., the dramatic post-scaling reduction in spirochetes/~1 in the perio-
dontal pockets associated with teeth numbers 3 and 19 is also in accord-
68 
ance with the findings of a recent study by Syed et al. They found 
that the effects of initial, nonsurgical periodontal therapy resulted in 
a significant reduction of spirochetes. 
An aberration occurred in the result of the spirochete counts/~1 
in the periodontal pocket associated with tooth number 19 of patient B.F. 
during week eight. Due to an error in the sampling technique the spiro-
chete count was zero. The effect of sampling on the composition of the 
human subgingival microbial flora was studied by Mousques, Listgarten 
69 
and Stoller. They observed clear-cut changes from baseline to day 3 
in the proportions of spirochetes and motile cells after sampling of 
periodontal pockets in 18 adults with chronic periodontitis. The sub-
sequent lack of change from the 3 day through the 42 day intervals sug-
gested that sampling per se may have contributed only to the changes 
37 
from baseline noted in the first few days. Thus, the aberration that 
occurred in the current study during week eight was not a result of the 
previous sampling, but rather a result of human error in the sampling 
technique during week eight. 
In the experimental group B, the spirochetes/~1 were totally elim-
inated in three of the six periodontal pockets after scaling, root plan-
ing, and minocycline therapy. These findings are enhanced by data pre-
48 
sented by Ciancio et al. who enumerated the subgingival microbial 
flora in 26 periodontitis patients by phase contrast microscopy. In the 
13 patients treated by half mouth scaling, root planing and orally ad-
ministered Minocin, they observed complete elimination of spirochetes 
for periods up to two months. In the current investigation, the spiro-
chete counts in four of the six pockets from experimental group B re-
mained below the pre-treatment counts at the completion of the study. 
However, in no instance were the spirochetes eliminated completely for 
as long as two months. 
When comparing control group A to experimental group B there was 
a tendency for the experimental group to further prolong the subgingival 
repopulation of motile rods. Because of the small sample size such a 
trend could not be extrapolated from the subgingival repopulation of the 
spirochetes in groups A and B. This trend is strengthened by the 1978 
20 
study of Listgarten, L·indhe and Hellden. Their tetracycline and scal-
ing sites showed essentially similar microbiological changes as the 
scaling only sites at the 0-, 8- and 25-week intervals. However, in the 
38 
presence of the antibiotic the 8-week proportions of motile rods and 
20 
spirochetes were lower than in the scaling only sites. Experimental 
group B, like control group A, showed a tendency for the GI scores and 
PO measurements to correspond directly with the counts/~1 of spirochetes 
or motile rods. 
In the experimental group C patient, R.S., the motile rods were 
more effectively inhibited by the penicillin than were the spirochetes. 
Moreover, the spirochetes were never totally eliminated by scaling, root 
planing and penicillin in group C as they were by scaling, root planing 
and minocycline in three pocket sites in group B. There was also a 
tendency for the subgingival repopulation of the motile rods to be more 
prolonged in the minocycline experimental group than in the penicillin 
70,71 
experimental group. However,~ vitro studies by Mashimo et al. 
have shown that penicillin is inhibitory to most periodontopathic bac-
71 
teria. In their 1981 study, Mashimo et al. found that penicillin was 
the most effective agent to control subgingival plaque flora at concen-
trations of .1, 1 and 5 ~g/ml. In another~ vitro study, Walker and 
72 
coworkers determined that most potential periodontopathic bacteria 
were sensitive to penicillin. They also encountered several strains of 
Selenomonas sputigena and Bacteroides melaninogenicus subspecies inter-
medius that produced beta-lactamases which could destroy penicillin in 
the periodontal pocket. 
In this investigation no trends were observed from the sporadic 
neutrophil count. These findings confirm data presented by Claffey et 
39 
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al. in 1982. They found no significant difference between deterior-
ating periodontal pocket sites and stable or improving sites in the leu-
kocyte counts taken from subgingival washings. Of all the parameters 
evaluated at 12 months, only probing pocket depth showed significant 
differences between those sites. Conversely, in a recent study by Keyes 
74 
and coworkers, they concluded that the assessed change in pattern and 
amount of plaque microbiota and white blood cells is clinically useful 
in determining efficacy of therapy in destructive periodontitis. Their 
subgingival root surface plaque samples were removed with a curette and 
quickly transferred to either a drop of tap water or physiologic saline 
on clean microscopic slides. Attempts to disperse, dilute or stain the 
samples were not made. Every effort was made to examine the bacterial 
complexes 11 intact 11 after removal from the circumradicular spaces by phase-
75 
contrast microscopy. In another study, Keyes et al. examined the high-
ly organized aggregations of aquatic microlife found in samples removed 
from root surfaces of pockets in patients with chronic destructive perio-
dontitis. Besides the highly organized motile rods and spirochetes, the 
vast accumulation of leukocytes in the too-numerous-to-count range was 
another predominant feature found in destructive periodontitis. The dis-
crepancy in the leukocyte counts between the current investigation and 
the studies by Keyes et al. appears to be due to the different sampling 
techniques performed. 
In this study it was shown that the seven day Minocin regime no-
ticeably reduced the spirochetes and motile rods. By means of darkfield 
40 
microscopic counts of subgingival microbial samples, distinct patterns 
in the counts/~1 of motile rods and spirochetes were demonstrated before 
and after scaling, root planing and minocycline therapy. Moreover, it 
19 
has been shown by Listgarten and Hellden that the proportion of motile 
rods and spirochetes was significantly higher at diseased sites as com-
23 
pared to healthy sites. In a subsequent study, Listgarten and Levin 
found that a subgingival microbiota rich in spirochetes, with or without 
motile rods, tended to precede a clinically detectable deterioration of 
the periodontium as determined by subsequent increases in probing depth 
measurements. Thus, spirochetes and motile rods may not be primary path-
ogens, but may act simply as indicator organisms of a pathogenic micro-
biota and to some extent as predictors of future clinical deteriora-
76 76,77 
tion. Listgarten and Schifter feel that these organisms can be 
monitored by darkfield microscopy so as to facilitate the optimal sched-
uling of recall visits for the maintenance of periodontal health. 
The series of darkfield and electron microscopic studies by List-
18,19,23 
garten and coworkers and the phase-contrast microscopic observa-
74,75 
tions by Keyes et al. have shown that spirochetes are abundant in 
the periodontal pockets characteristic of periodontitis. This finding 
is confirmed by the present study in which spirochetes were the pre-
dominant microorganism found in the majority of the pre-treatment perio-
dontal pockets (Tables 8-17). Accordingly, Loesch and Laughon feel 
that such bacterial specificity is evidence in support of the role of 
spirochetes in periodontal disease. In an excellent 1982 review 
41 
78 
article, they cite several association and response-to-treatment studies 
which make a strong argument for the involvement of spirochetes in all 
forms of periodontal disease except possibly localized juvenile periodon-
titis. Because spirochetes account for 35 to 55% of the flora before 
treatment, and then drop significantly to below 10% as a result of treat-
ment which restores periodontal health, they must be considered periodon-
78 
topathic organisms. 
This study showed that the seven day Minocin regime which commenced 
2 to 3 weeks after full mouth scaling and root planing was effective in 
reducing clinical and microbiological parameters in three patients with 
moderate periodontitis. However, an antibiotic should not be chosen 
arbitrarily but should be selected to meet the needs of the case. This 
selection must be based upon a knowledge of (1) the state of the pa-
tient's general health, (2) the nature of the specific infection in-
volved, (3) the pharmacology of the drugs available, and (4) the host-
66,79 
bacterium response to treatment. 
Chemotherapeutic treatment, without due regard for these basic 
parameters, usually turns into a superficial preoccupation with the iso-
lation of supposed pathogens and the dispensing of antibacterial agents. 
This 11 magic bullet 11 approach ignores the fact that these agents do not 
completely eliminate bacteria but merely give the host an opportunity to 
remove the microorganisms, or to reestablish a balance which is compat-
79 
ible with health. Consequently, minocycline treatment for moderate 
periodontitis is most effective when used as an adjunct to conventional 
42 
periodontal therapy. The optimal dose regimen and the optimal route of 
administration of this antibiotic remain to be established in subsequent 
studies. 
CHAPTER VI 
SUMMARY AND CONCLUSIONS 
The present study demonstrated that in five patients with moderate 
periodontitis, treatment that consisted of either scaling and root alone 
or in conjunction with orally administered minocycline or penicillin, re-
sulted in a decrease in the nine week post-treatment Gingival Index scores 
and decreased probing depths. In addition, the kinetics of the subgingi-
val bacterial repopulation were effected by these three treatment modali-
ties quantitatively and qualitatively. 
Minocycline hydrochloride is a semi-synthetic tetracycline that 
concentrates in the gingival crevicular fluid and can be given in lower 
and less frequent doses than tetracycline hydrochloride. Minocin treat-
ment for moderate periodontitis is most effective when used as an adjunct 
to scaling and root planing. 
Darkfield microscopy is an excellent technique to monitor the re-
colonization patterns of the subgingival microbial flora after perio-
dontal therapy. In the present investigation, darkfield microscopic ex-
amination showed that the counts/~1 of motile rods and spirochetes be-
fore and after treatment corresponded directly with changes in the clin-
ical parameters. In the Minocin group there was a tendency to further 
prolong the subgingival repopulation of motile rods as opposed to the 
control group. Each of these treatment modalities was shown to be more 
43 
44 
effective against spirochetes than the adjunctive penicillin group. Sta-
tistics were not utilized in this study because of the small sample size. 
Any antibiotic should not be chosen arbitrarily but should be selec-
ted to meet the needs of the case. This selection must be based upon a 
knowledge of (1) the state of the patient's general health, (2) the 
nature of the specific infection involved, (3) the pharmacology of the 
66,79 
drugs available, and {4) the host-bacterium response to treatment. 
Table 1. Profile and Baseline Measurements of Study Participants. 
Periodontal 
Pocket and Plague Probing Gingival 
Patient Age Race Sex Sample Sit~ Depth I nde}(_ _(~_!1 
JK 36 Indian M 3 MB* 5 2 
19 DB 4 2 
(Ex~erimental Grou~ B) 
BM 48 Caucasian M 3 MB 4 2 
19 DB 6 2 
(Ex~erimental GrouR B) 
BP 40 Caucasian F 3 DB 7 2 
19 MB 4 2 
(Experimental Group B) 
BF 42 Indian F 3 DP 7 1. 75 
19 ML 4 1.75 
(Control Group A) 
RS 38 Caucasian M 3 MB 7 2 
19 ML 7 2 
( ~xperimenta l __ Group C) 
M refers to mesial, B to buccal, D to distal, L to lingual, P to palatal 
Treatment 
Proposed 
OHI, Sc & 
RP, Me** 
OHI, Sc & 
RP, Me 
OHI, Sc & 
RP, Me 
OHI, Sc 
& RP 
OHI, Sc 
& RP 
* 
** OHI refers to oral hygiene instruction, Sc & RP to scaling and root planing, 
Me to minocycline 
.j:::. 
U1 
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Table 3. Gingival Index (GI) and Probing Depth (PO) of Selected 
Periodontal Pockets Associated with Teeth Numbers 3 and 
19 of Control Group A, Patient B.F. 
TIME GINGIVAL INDEX (GI) PROBING DEPTH (PO~ 
Pre-scaling and 3 19 3DP* 19ML* 
root planing 1.75 1.75 -7- -4-
2-3 weeks 
post-scaling and 
root planing = Day 0 1.25 1.25 5 3 
Week 1 1.25 1.25 5 2 
Week 4 1.5 1.5 4 2 
Week 8 1.5 1.25 4 2 
Week 9 1.5 1.75 4 3 
* D refers to distal, P to palatal, M to mesial, L to lingual, B to buccal 
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Table 4. GI and PO of Selected Periodontal 
Pockets Associated with Teeth 
Numbers 3 and 19 of Experimental 
Group B, Patient J.K. 
TIME GINGIVAL INDEX (GI) PROBING DEPTH {PO} 
Pre-scaling and 3 19 3MB l9DB 
root planing 2 2 -5- -4-
2-3 weeks 
post-scaling·and 
root planing = Day 0 1.5 1.75 5 3 
Week 1 1 1.25 3 3 
Week 4 1 1.25 3 3 
Week 8 2 2 4 5 
Week 9 2 1.75 5 4 
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Table 5. GI and PO of Selected Periodontal 
Pockets Associated with Teeth 
Numbers 3 and 19 of Experimental 
Group B, Patient B.M. 
TIME GINGIVAL INDEX (GI) PROBING DEPTH (PO} 
Pre-scaling and 3 19 3MB l9DB 
root planing 2 2 4 -6-
2-3 weeks 
post-scaling and 
root planing = Day 0 1.75 1.25 4 5 
Week 1 1 1 3 5 
Week 4 1 1 3 5 
Week 8 1.5 1.25 3 5 
Week 9 1.5 1.25 3 5 
Table 6. GI and PD of Selected Periodontal 
Pockets Associated with Teeth 
Numbers 3 and 19 of Experimental 
Group B, Patient B.P. 
TIME GINGIVAL INDEX (GI) PROBING DEPTH (PD) 
Pre-scaling and 3 19 3DB 19MB 
root planing 2 2 -7- -4-
2-3 weeks 
post-scaling and 
root planing = Day 0 1.75 2 5 4 
Week 1 1.25 1.5 3 3 
Week 4 1.5 1.5 4 3 
Week 8 (missed) (missed) (missed) (missed) 
Week 9 1.75 1.5 4 3 
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Table 7. GI and PO of Selected Periodontal 
Pockets Associated with Teeth 
Numbers 3 and 19 of Experimental 
Group C, Patient R.S. 
TIME GINGIVAL INDEX (GI) PROBING DEPTH {PO} 
Pre-scaling and 3 19 3MB l9ML 
root planing 2 2 -7- -7-
2-3 weeks 
post-scaling and 
root planing = Day 0 1.5 1.5 7 7 
Week 1 1.25 1.25 5 6 
Week 4 1.5 1.5 7 6 
Week 8 1.75 l. 75 7 7 
Week 9 1.5 1.75 7 7 
Table 8. Tooth Number 3 Counts/~1 of Spirochetes, 
Motile Rods and Non-motile Forms of 
Control Group A, Patient B.F. 
Time Spirochetes 
Pre-scaling and 6.60 x 10 3 
root planing 
2-3 Weeks 1.80 x 10 3 
Post-scaling and 
root planing = Day 0 
Week 1 0.00 
Week 4 2.77 x 10 3 
Week 8 1.54 x 10 3 
Week 9 2.05 x 10 3 
Motile 
Rods 
2.60 X 104 
2.57 X 10 3 
1 . 54 X 10 3 
4.01 X 10 3 
1.85 X 104 
8.73 X 10 3 
Non-motile 
Forms 
1.19 X 10 4 
1 . 31 x 1 a~+ 
2.08 X 104 
2.53 X 104 
6.08 X 101+ 
4.36 X 104 
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Table 9. Tooth Number 19 Counts/~1 of Spirochetes, 
Motile Rods and Non-motile Forms of 
Control Group A, Patient B.F. 
Time Spirochetes 
Pre-scaling and 2.02 x 104 
root planing 
2-3 Weeks 0.00 
Post-scaling and 
root planing = Day 0 
Week 1 0.00 
Week 4 7.92 x 10 3 
Week 8 0.00 
Week 9 4.93 x 104 
Motile 
Rods 
l .32 X 10 4 
2.57 X 10 2 
2.05 X 10 3 
8.80 X 10 3 
4.11 X 10 3 
l .36 X lOS 
Non-motile 
Forms 
6.69 X 104 
2.03 X 104 
1.41 X 104 
2.82 X 104 
4.16 X l 04 
l .48 X lQS 
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Table 10. Tooth Number 3 Counts/~1 of Spirochetes, 
Motile Rods and Non-motile Forms of 
Experimental Group B, Patient J.K. 
Motile Non-motile 
Time S~irochetes Rods Forms 
Pre-scaling and 6.16 X 104 2.88 X 104 3. 18 X 104 
root planing 
2-3 Weeks 2.46 X 10 4 1.58 X 104 3.70 X 104 
Post-scaling and 
root planing = Day 0 
Week 1 2.57 X 102 2.57 X 10 3 l .44 X 104 
Week 4 6.93 X 103 4.88 X 10 3 1.05 X 104 
Week 8 l .23 X lQS l. 17 X 1 as 3.08 X 104 
Week 9 1 .23 X lQS 2.34 X lOS 9.86 X 104 
Table 11. Tooth Number 19 Counts/~1 of Spirochetes, 
Motile Rods and Non-motile Forms of 
Experimental Group B, Patient J.K. 
Motile Non-motile 
Time SEirochetes Rods Forms 
Pre-scaling and 1 .81 X lOS 3.90 X 104 5.14 X 104 
root planing 
2-3 Weeks 6.37 X 104 2.67 X 104 1.23x104 
Post-scaling and 
root planing = Day 0 
Week 1 7.70 X 102 4.88 X 10 3 1 .34 X 104 
Week 4 1.85 X 10 4 1 .54 X 104 2.36 X 104 
Week 8 5.39 X 104 5.55 X 104 4.47 X 104 
Week 9 1 .07 X lQS 7.40 X 104 4.93 X 104 
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Table 12. Tooth Number 3 Counts/~1 of Spirochetes, 
Motile Rods and Non-motile Forms of 
Experimental Group B, Patient B.M. 
Motile Non-motile 
Time Seirochetes Rods Forms 
Pre-scaling and 3.08 X 10 5 1 . 36 X 105 1.11 X 10 5 
root planing 
2-3 Weeks 1 .64 X 10 5 1 .40 X 10 5 4.11 X 104 
Post-scaling and 
root planing = Day 0 
Week 1 8.80 X 102 2.86 X 104 1.72 X 104 
Week 4 2.11 X 104 1.98 X 104 4.40 X 10 3 
Week 8 1 .05 X 10 5 9.86 X 104 2.46 X 104 
Week 9 9.24 X 104 7.60 X 104 4.93 X 104 
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Table 13. Tooth Number 19 Counts/~1 of Spirochetes, 
Motile Rods and Non-motile Forms of 
Experimental Group B, Patient B.M. 
Motile Non-motile 
Time S~irochetes Rods Forms 
Pre-scaling and 2.46 X 10 5 1. 36 X 105 6. 16 X 104 
root planing 
2-3 Weeks 1 .23 X 10 5 9.86 X 10 4 4.93 X 104 
Post-scaling and 
root planing = Day 0 
Week 1 0.00 2.80 X 104 4.01 X 103 
Week 4 1.28 X 104 2.57 X 103 2.46 X 104 
Week 8 3.45 X 104 7.52 X 104 2.22 X 104 
Week 9 3.70 X 104 2.67 X 10 4 8.22 X 103 
Table 14. Tooth Number 3 Counts/~l of Spirochetes, 
Motile Rods and Non-motile Forms of 
Experimental Group B, Patient B.P. 
Time Spirochetes 
Pre-scaling and 2.71 x 10 5 
root planing 
2-3 Weeks 6.68 x 104 
Post-scaling and 
root planing = Day 0 
Week 1 0.00 
Week 4 9.45 x 104 
Motile 
Rods 
8.63 X 104 
3.90 X 104 
3.13 X 104 
9.66 X 104 
Non-motile 
Rods 
4.93 X 104 
4.72 X 104 
1 .49 X 104 
2.05 X 104 
Week 8 - unavailable for data collection -
Week 9 7.64 X 104 4.07 X 104 1 . 36 X 104 
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Table 15. Tooth Number 19 Counts/~l of Spirochetes, 
Motile Rods and Non-motile Forms of 
Experimental Group B, Patient B.P. 
Time Spirochetes 
Pre-scaling and 3.47 x 104 
root planing 
2-3 Weeks 2.77 x 104 
Post-scaling and 
root planing = Day 0 
Week l 0.00 
Week 4 7.70 x 10 3 
Motile 
Rods 
2.39 X 104 
5.96 X 104 
l . 95 X l 04 
1 .06 X lOS 
Non-motile 
Rods 
2.08 X 104 
3.39 X 104 
2.98 X 104 
7.24 X 104 
Week 8 - unavailable for data collection -
Week 9 1 .27 X lOS 3.70 X 104 4.52 X 104 
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Table 16. Tooth Number 3 Counts/~1 of Spirochetes, 
Motile Rods and Non-motile Forms of 
Experimental Group C, Patient R.S. 
Time Spirochetes 
Pre-scaling and 7.09 x 104 
root planing 
2-3 Weeks 5.87 x 102 
Post-scaling and 
root planing = Day 0 
Week 1 5.14 x 102 
Week 4 3.39 x 104 
Week 8 9.86 x 104 
Week 9 3.47 x 104 
Motile 
Rods 
2.65 X 10 5 
1.70 X 104 
1.54 X 10 3 
1 .23 X 104 
1 .97 X 10 5 
3.78 X 104 
Non-motile 
Rods 
8.01 X 104 
4.28 X 104 
9.76 X 10 3 
4.40 X 102 
9.86 X 104 
7.70 X 10 3 
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Table 17. Tooth Number 19 Counts/~1 of Spirochetes, 
Motile Rods and Non-motile Forms of 
Experimental Group C, Patient R.S. 
Motile Non-motile 
Time SEirochetes Rods Rods 
Pre-scaling and 3.08 X 10 5 2.65 X 105 1 .36 X 10 5 
root planing 
2-3 Weeks 1.03xl03 7.19 X 10 3 2.93 X 104 
Post-scaling and 
root planing = Day 0 
Week 1 2.57 X 102 7.70 X 102 4.11 X 10 3 
Week 4 1 .09 X 105 4.31 X 104 3.08 X 10 3 
Week 8 1.54 X 104 3.08 X 104 3.47 X 104 
Week 9 5.18 X 104 3.20 X 104 5.05 X 104 
Subject and 
Pocket Site 
B.F. - 3 DP 
B. F. - 19 ML 
J. K. - 3 MB 
J. K. - 19 DB 
B.M. - 3 MB 
B .M. - 19 DB 
B .P. - 3 DB 
B. P. - 19 MB 
R.S. - 3 MB 
R. S. - 19 ML 
Table 18. Neutrophil Counts from the Plaque Samples Obtained from the Selected 
Periodontal Pockets Associated with Teeth Numbers 3 and 19. 
2-3 Weeks 
Pre-scaling Post-scaling = Da~ 0 Week 1 Week 4 Week 8 Week 9 
2 14 1 0 2 0 
0 0 0 0 2 0 
0 0 0 0 0 0 
0 0 0 0 1 1 
0 0 0 0 0 0 
0 1 0 3 20 1 
0 0 1 0 missed 0 
1 0 0 0 missed 0 
0 0 3 0 0 1 
0 0 10 3 0 0 
0"1 
...... 
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Figure l. Sample of the informed consent form. 
IRB NUMBER: 4/8l-5b 
LOYOLA UNIVERSITY MEDICAL CENTER 
MAYWOOD, ILLINOIS 
DEPARTMENT OF PERIODONTICS 
INFORMED CONSENT 
Patient•s Name: Date: 
----------
Project Title: The Effect of Systemic Minocycline Therapy on the 
Microflora in Moderate Periodontitis. 
Patient Information 
Description and explanation of procedure: As a result of periodontal (gum) 
disease, you have many periodontal pockets that are filled with harmful 
bacteria that cause destruction of the gum and bone tissue which surround 
the teeth. Minocycline (Minocin) is a tetracycline antibiotic ordinarily 
used against bacterial infections including periodontal disease. You will 
be asked to take orally 150 mg of minocycline (Minocin) (50 mg in the morn-
ing and 100 mg in the evening) for seven days as protection against perio-
dontal bacteria. 
Risks and discomforts: Minocycline should not be given to pregnant women; 
patients with renal (kidney) impairment; or children up to eight years of 
age. Dizziness may occur with minocycline. 
Potential benefits: The suppression of the injurious bacteria that are 
causing your periodontal disease and an improvement in the health of your 
gums. The possible regrowth of normal bone to tooth and tooth to gum 
attachment. 
Treatment Alternatives: The surgical eradication of periodontal pockets 
via the separation of the gum tissue from the tooth and bone, and the re-
contouring of bone around the tooth (with surgical burs and instruments). 
The gum tissue is then replaced and sutured together. Alternatives to 
participation include total withdrawal from the study. 
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Consent 
I have fully explained to 
the nat u re and purpose of -:-t7"-h e-a'b_o_v_e --d,..e_s_c_r"T"i 'be-d.---p_r_o_c e-d.-u_r_e_a n-d;--;t-;-h-e--:-:-:n:;-:. s:ok:-:s--;--t;:-h a:-Lt 
are involved in its performance. I have answered and will answer all ques-
tions to the best of my ability. 
Stephen A. Folson, D.D.S. 
I have been fully informed of the above-described procedure with its pos-
sible benefits and risks. I give permission for my participation in this 
study. I know that Dr. Stephen Folson or his associates will be available 
to answer any questions I may have. If, at any time, I feel my questions 
have not been adequately answered, I may request to speak with a member 
of the Medical Center Institutional Review Board. I understand that I am 
free to withdraw this consent and discontinue participation in· this pro-
ject at any time without prejudice to my medical care. I have received a 
copy of this informed consent document. 
I understand that biomedical or behavioral research such as that in which 
I have agreed to participate, by its nature, involves risk of injury. In 
the event of physical injury resulting from these research procedures, 
emergency medical treatment will be provided at no cost, in accordance 
with the policy of Loyola University Medical Center. No additional free 
medical treatment or compensation will be provided except as required by 
Illinois law. 
In the event I believe that I have suffered any physical injury as the 
result of participation in the research program, I may contact, Dr. S. 
Aladjem, Chairman, Institutional Review Board for the Protection of Human 
Subjects at the Medical Center, telephone (312) 531-3380. 
I agree to allow my name and medical records to be available to other 
authorized physicians and researchers for the purpose of evaluating the 
results of this study. I consent to the publication of any data which 
may result from these investigations for the purpose of advancing medical 
knowledge, providing my name is not used in conjunction with such publi-
cation. All precautions to maintain confidentiality of the medical 
records will be taken. 
(signature: patient 
(signature: witness to signature) 
Figure 2. Experimental design schematically summarized. 
Control 
Group A - 2 subjects Experimental Group B - 3 subjects 
' 
t 
Baseline measurements-teeth #'s 3 and 19* 
Oral hygiene instruction 
Full mouth scaling 
and root planing 
' 
GI, PO, PS ._ = 2-3 weeks post-scaling .. GI, PO, PS 
and root planing = Day 0 
' Oral hygiene .. Day 1 .. 150 mg of minocycline only for (Minocin) taken orally 
remainder of study for one week (50 mg in 
the morning and 100 mg 
in the evening) plus 
oral hygiene 
GI, PO, PS .. Week 1 ... GI, PO, PS 
~ Oral hygiene only for remainder of study 
GI, PD, PS Week 4 .. GI, PD, PS 
+ GI, PO, PS ... Week 8 .. GI, PO, PS 
+ GI, PD, PS ... Week 9 • GI, PO, PS 
' 
Study completed 
*Gingival Index (GI), probing depth (PD), plaque sample (PS) 
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Figure 3. 
Sample of a darkfield microscopic microbial and neutrophil counting form. 
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DARJ<F!ELD MICROBIOLOGY 
ORAL BIOLOGY RESERACH PROJECT - Stepben A. Folson, D.D.S. 
PATIENT'S iW-1::: 
0BssqvATION DAY: 
TYPE I WBC I Toothk ~ Number y-and ~ 
Field <-"-0 Y 
Number ~~v ~~ 
-
Spirochetes l Motile Rods 
TYPE OF 
TREAT1"1ENT: 
DATE; 
(MJ/DAYIYR): 
I Non-Hotile O.rganism 
,.,,_.§' 
0. 
v"' 
/.,~ ~~~ ~<~ ~/ ~v~ L,/ ~/ / -~:. 
SUMMARY: Tooth number m1crol1ters/plague sample Total F1elds Total Cells 
I 
Figure 4. Darkfield microscopic calculations. 
1. Area under cover slip (5 ~1 sample): 
22 mm x 22 mm = 4.84 cm 2 1 sample 
2. Area of one field on oil immersion: 
3. 
n r 2 = rr (.Olcm) 2 = rr • 10- 4 cm 2/field 
5~1 rr . lo- 4cm 2 
Constant K = -- x 
sample field 
4.84 em 2/sample 
= 5 
-- rr·l0- 4 ~1/field 4.84 
80 
4. Microbial counts*/total fields converted to microbial counts/~1: 
counts/fields x l/K = counts/~1 
* spirochetes, motile rods, and the combined non-motile organisms 
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Figure 5. Gingival Index (GI) and probing depth (PO) of the selected 
periodontal pocket associated with tooth number 3 in the 
control group A, patient B.F. 
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Figure 6. GI and PD of the selected periodontal pocket associated 
with tooth number 19 in the control group A, patient B.F. 
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Figure 7. GI and PO of the selected periodontal pocket associated 
with tooth number 3 in the experimental group B, patient J.K. 
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Figure 8. GI and PD of the selected periodontal pocket associated 
with tooth number 19 in the experimental group B, patient J.K. 
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Figure 9. GI and PO of the selected periodontal pocket associated with 
tooth number 3 in the experimental group B, patient B.M. 
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Figure 10. GI and PD of the selected periodontal pocket associated with 
tooth number 19 in the experimental group B, patient B.M. 
3 
2 
Clinical Measurements --- Gl nglvol Index .•. •••. •• Prob I ng Depth 
Subject: B.M. #19 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
........................................................................................................................................................................................ ~--- ............... .. 
-------------·--·-······-· 
CJ l 
Pre-Test 
CJ 8 2 7 3 4 5 
T i rne Ct-leeksl 
6 9 
7 
6 s 
.5 
...c 
+ Q_ 
5 ill 
0 
CJ) 
c 
4 --
3 
2 
...0 
0 
L 
Q_ 
....... 
N 
X 
QJ 
LJ 
c 
1--f 
,...-
tO 
> 
·-(Jl 
c 
·-
l!J 
3 
2 
1 
Figure 11. GI and PD of the selected periodontal pocket associated with 
tooth number 3 in the experimental group B, patient B.P. 
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Figure 12. GI and PD of the selected periodontal pocket associated with 
tooth number 19 in the experimental group B, patient B.P. 
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Figure 13. GI and PD of the selected periodontal pocket associated with 
tooth number 3 in the experimental group C, patient R.S. 
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Figure 14. GI and PO of the selected periodontal pocket associated with 
tooth number 19 in the experimental group C, patient R.S. 
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Figure 15. Counts/~1 of spirochetes, motile rods and non-motile forms 
of the selected periodontal pocket associated with tooth 
number 3 in the control group A, patient B.F. 
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Figure 16. Counts/~1 of spirochetes, motile rods and non-motile forms 
of the selected periodontal pocket associated with tooth 
number 19 in the control group A, patient B.F. 
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Figure 17. Counts/~1 of spirochetes, motile rods and non-motile forms 
of the selected periodontal pocket associated with tooth 
number 3 in the experimental group B, patient J.K. 
1 
eJG J ~1 · ) f Sn J.-c·cl- ·,+e·- I I I --- -r- , _,. ,;t.\ .;: 
I C r 0 b I o 0! m 5 ·---····- !1::·t 11 e Rc:ci.s 
leJS 
Subject: J.K. u3 ......... tkn·-Motlle forms 
~--- ., ~-, 
.. 
1 .. ··. 
--- ... 
,• 
/-~ 
,..·.· 
./;•' 
~~·· 
.· 
,• 
' __ ,~--'<<:: .. -.. ---· .. 
.· 
,,·· 
,• 
/ 
.· 
.·· 
.· 
Q_ 1eJ4 ... ... .. ... ·- ...... -· -· .......... . 
_ ...... 
lfl .··"·' 
~ 
1 
c 
:J 
0 
_____ ...................... -····· 
u 
leJ3 
1eJ2 
Pre-Test 
eJ 2 3 4 5 
T I me c:.!e<:!k:•l 
6 7 8 9 
....... 
1..0 
,..--
:J 
L 
GJ 
Figure 18. Counts/~l of spirochetes, motile rods and non-motile forms 
of the selected periodontal pocket associated with tooth 
number 19 in the experimental group B, patient J.K. 
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Figure 19. Counts/~1 of spirochetes, motile rods and non-motile forms 
of the selected periodontal pocket associated with tooth 
number 3 in the experimental group B, patient B.M. 
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Figure 20. Counts/~1 of spirochetes, motile rods and non-motile forms 
of the selected periodontal pocket associated with tooth 
number 19 in the experimental group B, patient B.M. 
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Figure 21. Counts/~1 of spirochetes, motile rods and non-motile forms 
of the selected periodontal pocket associated with tooth 
number 3 in the experimental group B, patient B.P. 
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Figure 22. Counts/~l of spirochetes, motile rods and non-motile forms 
of the selected periodontal pocket associated with tooth 
number 19 in the experimental group B, patient B.P. 
1 CJ6 5 h . M 1 b 1 '] F __ pI roc e<es I C I 0 I a 0 I m S .. .... .... Mot 11 e Rods 
lCJS 
Subject: B.P. #19 ······-- Non-Motile forms 
' l·; ... ·--- \ ' ' 
- ··::.::::="~~·'-·::::.: ·:·~·~·:.·.:·.·.·.:·.:·::.:·::.~·.~·.:·.:·:· :·:·.-......... /"'-::""."::;:::::. 
.·· 
.............. 
0. 1CJ4 
I.(} 
+ 
c 
:J 
0 
u 
Hl3 
1CJ2 9 
Pre-Test 
CJ 2 3 4 5 
T i rn t= (:.Jeeksl 
5 7 8 
00 
..j::>. 
r--
:J 
L 
QJ 
Figure 23. Counts/~1 of spirochetes, motile rods and non-motile forms 
of the selected periodontal pocket associated with tooth 
number 3 in the experimental group C, patient R.S. 
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Figure 24. Counts/~l of spirochetes; motile rods and non-motile forms 
of the selected periodontal pocket associated with tooth 
number 19 in the experimental group C, patient R.S. 
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